Skip to main content

Table 2 Glucolipid metabolic indices of PHP1, normal control and PHPT

From: Explorative research on glucolipid metabolism and levels of adipokines in pseudohypoparathyroidism type 1 patients

 

PHP1 (n = 49)

Normal control (n = 30)

PHPT (n = 64)

p1

p2

p3

FBG (mmol/L)

4.80 ± 0.39

4.90 (4.30–6.00)

5.40 (3.80–14.30)

1.000

 < 0.001

 < 0.001

Ins (μIU/mL)

6.00 (1.90–17.50)

5.57 ± 2.85

7.80 (2.90–19.50)

1.000

0.005

0.031

HOMA-IR

1.24 (0.38–4.04)

1.24 ± 0.66

1.77 (0.71–8.01)

1.000

0.001

0.001

HOMA-IS

0.81 (0.25–2.63)

0.92 (0.35–3.91)

0.57 (0.12–1.41)

1.000

0.001

0.001

HOMA-β (%)

97.08 (26.25–312.50)

80.48 ± 41.53

72.40 (23.33–313.33)

0.060

0.961

0.028

TC (mmol/L)

4.37 ± 0.79

4.18 ± 0.71

4.88 ± 1.05

1.000

0.006

0.012

TG (mmol/L)

0.95 (0.33–2.63)

0.99 (0.31–2.95)

1.17 (0.31–4.22)

0.509

0.126

0.022

Hypertriglyceridemia [n, (%)]

8 (16.3%)

3 (10%)

13 (20.3%)

0.523

0.255

0.631

HDL-C (mmol/L)

1.26 (0.77–2.19)

1.26 (0.85–2.27)

1.32 ± 0.31

0.777

0.930

0.946

Hypo-HD-lipoproteinemia [n, (%)]

3 (6.1%)

1 (3.3%)

5 (7.8%)

0.146

0.707

0.228

LDL-C (mmol/L)

2.61 ± 0.62

2.62 ± 0.58

2.86 ± 0.94

0.616

0.150

0.045

Hyper-LD-lipoproteinemia [n, (%)]

5 (10.2%)

3 (10%)

16 (25%)

0.509

0.309

0.052

Leptin (ng/ml)

2.43 (0.10–6.39)

1.16 (0.09–9.02)

2.24 (0.10–8.24)

1.000

0.037

0.124

Adiponectin (μg/ml)

4.64 (2.27–81.80)

5.39 ± 3.05

4.95 (1.80–12.24)

0.889

0.964

0.977

FGF21 (pg/ml)

167.46 (17.82–975.23)

165.29 (63.19–649.68)

255.74 (45.59–847.88)

1.000

0.094

0.019

TNFα (pg/ml)

10.74 ± 4.13

15.47 ± 6.65

11.48 (3.82–44.61)

0.002

0.041

0.481

LAR

0.19 (0.01–3.19)

0.34 (0.02–2.26)

0.50 (0.01–2.24)

0.604

0.062

0.141

  1. PHP1: pseudohypoparathyroidism type 1; PHPT: primary hyperparathyroidism; FBG: fasting blood glucose; Ins: insulin; HOMA-IR: homeostasis model assessment-insulin resistance; HOMA-IS: homeostasis model assessment-insulin sensitivity; HOMA-β: homeostasis model assessment-beta cell function; TC: total cholesterol; TG: triglyceride; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; FGF21: fibroblast growth factor 21; TNFα: tumor necrosis factor α; LAR: leptin/adiponectin ratio; p1: p-value for comparison between PHP1 and normal control; p2: p-value for comparison between PHPT and normal control; p3: p-value for comparison between PHP1 and PHPT. p-value of less than 0.05 would be considered as of significantly difference